Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Wanxin Bio-Technology

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of drugs and vaccines. The company's products specialize in the genetically engineered recombinant protein drugs and vaccines which respond to a wide range of diseases, including malaria and hepatitis.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Acquirer
Primary Office
  • Shanghai
  • China

Wanxin Bio-Technology Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Wanxin Bio-Technology‘s full profile, request access.

Request full access to PitchBook